SCHEMBL24035183

SCHEMBL24035183

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1cc(Br)nn1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
GRN P28799 1/20 0.40
SORT1 Q99523 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
GPR119 Q8TDV5 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
RECQL P46063 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
GAA P10253 1/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
RIPK1 Q13546 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19253466 0.78 KDM4E (0.31) GRNSORT1HTR2CSLC6A4MAPK14
SCHEMBL15025622 0.77 GRN (0.41) GRNSORT1RXFP1RECQLGAA
SCHEMBL19253513 0.69 HTR2C (0.36) HTR2CSLC6A4GAA
SCHEMBL21872232 0.69 BRD4 (0.36) GRNSORT1HTR2CSLC6A4KDM4E
SCHEMBL17129943 0.68 NTRK1 (0.40) ALDH1A1GRNSORT1SMN1; SMN2NPC1
SCHEMBL17129949 0.68 CHEK1 (0.37) ALDH1A1GRNSORT1SMN1; SMN2NPC1
SCHEMBL8736767 0.67 MEN1 (0.43) ALDH1A1SMN1; SMN2RAB9AKMT2AHSD17B10
SCHEMBL17112361 0.67 FGFR1 (0.42) ALDH1A1SMN1; SMN2NPC1LMNATP53
SCHEMBL17129863 0.67 FGFR1 (0.44) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL16112407 0.67 SMN1; SMN2 (0.59) ALDH1A1GRNSORT1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807644-B2 Methods and compounds for restoring mutant p53 function PMV PHARMACEUTICALS, INC. (US) 2023-11-07 US disclosed
US-11807644-B2 Methods and compounds for restoring mutant p53 function PMV PHARMACEUTICALS, INC. (US) 2023-11-07 US disclosed
EP-4149459-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV Pharmaceuticals, Inc. (US) 2023-03-22 EP disclosed
WO-2021231474-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807644-B2 Methods and compounds for restoring mutant p53 function TP53, TP53BP1, HRAS ALDH1A1 1977/4885GRN 1109/4885SORT1 4027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.